Today's action "An experimental antibody made in the

New Post Public Reply Private Reply Replies (0) Message Board
oMandarin sean007 #126633
1,239
Today's action


"An experimental antibody made in the lab can completely protect non-human primates from contracting simian-type HIV, according to a new study published in the academic journal Nature Communications.

"Our findings suggest that the monoclonal antibody leronlimab may be a new weapon in the fight against the HIV epidemic," said the study's principal investigator and the paper's co-corresponding author, Jonah Sacha, Ph.D., a professor at Oregon Health Sciences University, inaugural at the Oregon National Primate Center and the Vaccine and Gene Therapy Institute

The results of this study will inform future human clinical trials to evaluate the monoclonal antibody leronlimab as a potential HIV pre-exposure prophylaxis (PrEP) to prevent HIV infection in humans.

“We basically have a tool that mimics the genetic mutation of CCR5 that made some people immune to infection and to some extent cured 2 HIV cases. The results of preclinical studies targeting the HIV co-receptor CCR5 have Breakthrough potential," said Liomwa Ndhlovu, MD, another co-corresponding author and professor of immunology at Weill Cornell Medical College in New York.

The monoclonal antibody, made by Vancouver, Washington-based CytoDyn, blocks HIV from passing through a surface protein called CCR5 by XX immune cells. This injectable drug is already being studied in Phase 3 trials as a potential treatment in combination with standard antiviral drugs.

Currently, CytoDyn is submitting relevant information to the FDA for FDA approval. However, the study began by specifically investigating how to prevent HIV infection.

Some PrEP drugs are already on the market, but they can cause unwanted side effects, such as liver, heart and bone problems, and some HIV genetic mutations can also make PrEP drugs resistant. Existing PrEP regimens often require frequent use, such as one tablet per day, or must be administered in an outpatient setting. Leronlimab is designed to self-inject XX.

To study the effectiveness of leronlimab as a potential PrEP drug, the research team created three experimental groups of six rhesus monkeys at the Oregon National Primate Research Center in Oregon. Two groups received different doses of leronlimab, while the third group served as a control group and received no experimental drug.

A group of macaques received XX high doses of leronlimab every other week at a dose of 50 mg/kg body weight, at which the macaques were completely protected from simian HIV infection. In contrast, two rhesus monkeys receiving weekly 10 mg/kg doses of XX were infected with HIV, and all rhesus monkeys in the control group were infected. The researchers concluded that part of the protection in the low-dose group may be due to the macaques' immune response to human antibodies.

Caption: Dr. Jonah Sacha

Based on the results of the study, CytoDyn plans to conduct an initial clinical trial next year to study leronlimab as a potential PrEP drug in people. Since mud monkey cells have more surface CCR5 protein than humans, the human dose may be lower than that given in this study.

Meanwhile, Dr. Sacha is already working to make leronlimab easier to use. In August 2020, he received a 5-year, $3 million grant from the National Institutes of Health (NIH) to develop a concentrated, longer-lasting formulation of leronlimab that can be injected every three months. Infrequent injection of XX can increase compliance with drug therapy, thereby improving the effectiveness of the drug.

The research team dedicated the study to Timothy Ray Brown, known as the Berlin Patient, who died on September 29, 2020, the first person to be cured of AIDS, for which Brown is known. While living in Berlin in 2007, Brown underwent a bone marrow transplant to treat his blood cancer. The process eliminated Brown's HIV because the transplanted bone marrow came from a donor with a rare genetic mutation that eliminated the CCR5 gene, the surface protein of HIV XX cells. Dr. Sacha and Brown met and became friends at an AIDS conference in 2015. Brown is also a co-author of the paper because he inspired the scientists working on the research.

Source: Red Maple Bay

Disclaimer: This official account is for public health publicity and is not for commercial purposes. Some materials come from the Internet. If any text, pictures, videos or other content involves infringement or violation, please contact us to delete and modify it, thank you!"

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 166

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 129

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 112

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 111

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 131

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Blast Doubles Athabasca Ground, but Drills Still Matter

Updated Category News Views 75

More ground in Athabasca can wake up a uranium junior fast, and Blast Resources has certainly grabbed investors’ attention with this one. The company has optioned eight additional uranium claims beside its Wales Lake property in northern Saskatchewan, taking its regional footprint from 12,150 hectares across 16 claims to 30,732 hectares across 24 claims. That is more...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 199

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 122

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading
Live Nation Tests Creator Content With Morgan Jay Series

Updated Category News Views 157

A comedian turning crowd work into songs is hardly a boardroom event, but this one has a useful wrinkle: Live Nation Studios put financing behind it. Morgan Jay and Austin-based agency Hello Party launched Music Therapy with Morgan Jay on YouTube on November 18, with Kam Patterson opening the season. The show pairs Jay and celebrity guests for loose conversation,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlueVoyant Launches Innovative Cybersecurity Solution for Enterprises

Updated Category News Views 249

BlueVoyant Introduces a Cutting-Edge Cybersecurity Solution BlueVoyant has launched its Continuous Optimization for Microsoft Security (COMS) service, marking a significant step in enterprise cybersecurity. This innovative solution is crafted to empower organizations with advanced threat detection and optimization strategies for Microsoft Security tools. Clients benefit...

Continue Reading
Prudential Advisors Welcomes New Talent and Grows Nationally

Updated Category News Views 224

Prudential Advisors' Remarkable Growth in 2025 Prudential Advisors is on an exciting journey, having welcomed an impressive wave of experienced financial advisors, significantly bolstering their national influence. Incorporating skilled advisors managing an astounding $3 billion in client assets marks a pivotal milestone for the firm. With nearly a 9% rise in advisor...

Continue Reading
Investors Unite: Solaris Energy Faces Class Action Lawsuit

Updated Category News Views 351

Understanding the Class Action Lawsuit Against Solaris Energy Infrastructure Recent developments have brought attention to Solaris Energy Infrastructure, Inc. and its ongoing class action lawsuit. Shareholders are encouraged to stand up for their rights as allegations arise concerning the company's practices and communications with investors. Details of the Allegations...

Continue Reading
Raising Awareness for Emergency Notification System Signs

Updated Category News Views 145

Understanding Emergency Notification System Signs As part of an ongoing effort to enhance safety at railroad crossings, Operation Lifesaver, Inc. (OLI), an esteemed national nonprofit dedicated to rail safety education, is launching its inaugural Emergency Notification System (ENS) Sign Awareness Day. This event is not just a one-time notice; it's an encouragement for all...

Continue Reading
Veolia and Mistral AI Unite to Transform Ecological Management

Updated Category News Views 361

Revolutionizing Resource Management with Generative AI Veolia, a prominent name in ecological transformation, is making waves by collaborating with Mistral AI, a leader in generative artificial intelligence. Their recent strategic partnership aims to redefine the management of industrial sites, focusing on water management, waste recycling, and local energy production....

Continue Reading